| Topic Name: |
A Question for the Bankers |
| Message Name: |
I agree |
| Date Posted: |
05/28/2000 |
| In Reply To: |
As much as I hate to voice support for the traders and salesguys, one thing I'd like to point out is that nobody pays bankers 7% to write salesforce memos, committee memos, or prospecti.
They pay the 7% to get their stock sold (distributed if you prefer a more clinical term), and to get research support.
If S&T goes the way of the dodo, all of us are screwed. Nobody will pay $3 million to have a bunch of bankers argue about the right way to write the MD&A. |
| Message: |
The two groups (IBD AND S&T) are joined at the hip through Capital Markets. I trade Equity Linked Products and am very happy our banking groups is capable of bringing deals to market even under the worst of market conditions. I am equall glad that our research force provides the ongoing research support that the companies and investors value. And I am also sure that each of the two groups is glad that they have a solid S&T operation to efficiently distribute and support their publically traded securities. All these trends in technology only hurt at the small trade level. No computer will ever handle the multimillion share block trades, and nor will online private placements handle billion dollar share offereings. And since these are the areas the BB are dominating in, I am not worried. Fair...lets shake and make up =P
|
|
